TechLink – Product innovation doesn’t have to stop because of R&D budget cuts


The coronavirus pandemic has educated the public on the fact that the discovery and development of pharmaceutical and health care products is a long and expensive process.

And while most business leaders say that innovation is a top priority, the number of businesses saying they don’t plan to invest in innovation has jumped from 8% to 25% since the coronavirus pandemic began, according to survey research reported by Sifted.

By Austin Leach, PhD, CLP

TechLink Staff Writer

News Catrgory Sponspor:

TechLink helps the Department of Defense to commercialize leading-edge new technology by partnering DoD labs with private sector companies for technology licensing, transfer, and research and development

News Catrgory Sponspor:

Dorsey & Whitney - An International business law firm, applying a business perspective to clients' needs in Missoula, Montana and beyond.

Leave a Comment

You must be logged in to post a comment.